Original document(18 pages)  中文版
    An antitumor combination comprising a 1,2-stilbene derivative and an anticancer compound selected from the group consisting of taxanes, alkylating agents, antimetabolites, vinca alkaloids, epidophylloptoxins, and antibiotics as the active ingredients is provided. Methods of using these pharmaceutical preparations for the treatment of solid carcinomas and the like are also provided.
Application Number
申请号		 200610138875 Application Date
申请日		 2002.03.15
Title 名称 Combination comprising combretastatin and anticancer agents
Publication Number
公开号		 1935134 Publication Date
公开日		 2007.03.28
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K31/337;A61K31/167;A61K31/4745;A61K31/47;A61K31/138;A61P35/00
Applicant(s) Name
申请人		 Aventis Pharma SA
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人 yuanzhi meng
More information 更  多  信  息


 Related patents information
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.